BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The ADC renaissance has continued to dominate the oncology fie
 ld throughout 2023\, with the long-awaited approval of ImmunoGen’s ELAHER
 E – the 9th ADC to be approved in just three years. To add to the excitem
 ent\, this incredible breakthrough is the first ADC for platinum-resistan
 t ovarian cancer\, proving their potential for treatments beyond breast c
 ancer.\n\nWhether you have just ventured into the ADC space or are an ADC
  guru\, the 14th World ADC San Diego has got you covered. Accompanying yo
 u from early discovery to late-stage manufacturing and regulatory challen
 ges\, this meeting has been designed with one aim in mind: to maximize th
 e therapeutic window of your ADC\, and propel ADCs to become life-changin
 g\, front-line treatments for oncology patients.\n\nWith over 800 world-l
 eading ADC experts in attendance including Daiichi Sankyo\, ImmunoGen\, A
 bbVie\, Gilead Sciences\, and Seagen\, this is set to be the biggest-ever
  convergence of the ADC community yet and you cannot afford to miss it!&n
 bsp\;\n
DTEND:20231019T160000
DTSTAMP:20260512T220333Z
DTSTART:20231016T090000
LOCATION:Sheraton San Diego Hotel & Marina\, 1380\, Harbor Island Drive\, 
 San Diego\, San Diego County\, 92101\,
SEQUENCE:0
SUMMARY:The ADC renaissance has continued to dominate the oncology field t
 hroughout 2023\, with the long-awaited approval of ImmunoGen’s ELAHERE – 
 the 9th A...
UID:0b7f33cd-96de-43b2-b550-cadf8085c987
END:VEVENT
END:VCALENDAR